QMS Medical Allied Services P/E Ratio
Current P/E Ratio
25.47
High Valuation
High - Growth expectations or overvalued
QMS Medical Allied Services (QMSMEDI) P/E ratio is 25.47 (High), EPS (TTM) ₹5.40, current price ₹131.92 on NSE — High - Growth expectations or overvalued. For live price, revenue and the complete fundamental profile, see QMSMEDI share price screener.
Current Valuation Metrics
P/E Ratio
25.47
Current Price
₹131.92
EPS (TTM)
₹5.40
Exchange
NSE
Valuation Signal
Signal
Overvalued
Sector Context
Sector Average
56.65
Sector Median
31.4
Sector Rank
#11 of 199
Sector Percentile
5.5%
Earnings Breakdown (TTM)
TTM EPS
₹6.60
Mar 2026
₹0.97
Jun 2026
₹2.05
QMSMEDI P/E Ratio — Valuation Signal & Historical Context
QMS Medical Allied Services P/E 25.47 — signal: Overvalued.
- Stock appears overvalued with PE of 25.47, suggesting caution for new investments
- Trading at discount to sector average PE of 56.65
QMSMEDI vs Healthcare Peers — P/E Ratio Comparison
QMS Medical Allied Services P/E 25.47 vs Healthcare average 56.65, median 31.4 — range 1.99–747.21.
Sector Average
56.65
Sector Median
31.4
Lowest P/E
1.99
Highest P/E
747.21
Companies
199
| Company | Symbol | P/E Ratio | Market Cap (₹ Cr) | Valuation |
|---|---|---|---|---|
| Sunrest Lifescience | SUNREST | 1.99 | ₹66 | Low |
| Murae Organisor | MURAE | 2.86 | ₹41 | Low |
| Colinz Laboratories | COLINZ | 3.21 | ₹9 | Low |
| Phaarmasia | PHRMASI | 3.45 | ₹60 | Low |
| Sun Pharma Advanced Rese… | SPARC | 4.03 | ₹6,361 | Low |
| Dipna Pharmachem | DPL | 4.65 | ₹12 | Low |
| JFL Life Sciences | JFLLIFE | 4.95 | ₹67 | Low |
| Shelter Pharma | SHELTER | 5.71 | ₹56 | Low |
| GKB Ophthalmics | GKB | 5.9 | ₹33 | Low |
| Kabra Drugs | KABRADG | 6.01 | ₹45 | Low |